摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-4-isopropyl-4,5-dihydrooxazol-2-amine | 1246679-92-4

中文名称
——
中文别名
——
英文名称
(R)-4-isopropyl-4,5-dihydrooxazol-2-amine
英文别名
2-amino-4-(S)-isopropyloxazoline;(4R)-4-propan-2-yl-4,5-dihydro-1,3-oxazol-2-amine
(R)-4-isopropyl-4,5-dihydrooxazol-2-amine化学式
CAS
1246679-92-4
化学式
C6H12N2O
mdl
——
分子量
128.174
InChiKey
RKTWYSWYCPYDJG-YFKPBYRVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    47.6
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    (R)-4-isopropyl-4,5-dihydrooxazol-2-amine 、 (3aR,8aS)-2-ethoxy-8,8a-dihydro-3aH-indeno[1,2-d]oxazole 在 对甲苯磺酸 作用下, 以 甲苯 为溶剂, 反应 48.0h, 以40%的产率得到(3aR,8aS)-N-((R)-4-isopropyl-4,5-dihydrooxazol-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-amine
    参考文献:
    名称:
    Development of Bifunctional Aza-Bis(oxazoline) Copper Catalysts for Enantioselective Henry Reaction
    摘要:
    Base-functionalized aza-bis(oxazoline) ligands were prepared to explore the concept of dual activation through the Lewis acid and a tethered tertiary amine base, The catalytic activity of the Cu complex was evaluated for the asymmetric Henry reaction. Compared with a corresponding unfunctionalized copper complex with external 1-benzyl-4-ethylpiperazine base, the ethylpiperazine-functionalized aza-bis(oxazoline) copper catalyst resulted in rate acceleration (2.5 times) as well as improved enantioselectivity (72% ee vs 92% ee).
    DOI:
    10.1021/jo1009867
  • 作为产物:
    描述:
    sodium cyanideD-缬氨醇 作用下, 以 甲醇 为溶剂, 以97%的产率得到(R)-4-isopropyl-4,5-dihydrooxazol-2-amine
    参考文献:
    名称:
    Development of Bifunctional Aza-Bis(oxazoline) Copper Catalysts for Enantioselective Henry Reaction
    摘要:
    Base-functionalized aza-bis(oxazoline) ligands were prepared to explore the concept of dual activation through the Lewis acid and a tethered tertiary amine base, The catalytic activity of the Cu complex was evaluated for the asymmetric Henry reaction. Compared with a corresponding unfunctionalized copper complex with external 1-benzyl-4-ethylpiperazine base, the ethylpiperazine-functionalized aza-bis(oxazoline) copper catalyst resulted in rate acceleration (2.5 times) as well as improved enantioselectivity (72% ee vs 92% ee).
    DOI:
    10.1021/jo1009867
点击查看最新优质反应信息

文献信息

  • [EN] BICYCLIC INHIBITORS OF ALK<br/>[FR] INHIBITEURS BICYCLIQUES DE L'ALK
    申请人:ABBOTT LAB
    公开号:WO2012097682A1
    公开(公告)日:2012-07-26
    The present invention relates to compounds of formula (1) or pharmaceutical acceptable salts, wherein R1, X, Y, Z, A, B, G1, and n are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as ALK and methods of treating diseases such as cancer.
    本发明涉及公式(1)的化合物或药用可接受的盐,其中R1、X、Y、Z、A、B、G1和n在描述中有定义。本发明还涉及含有上述化合物的组合物,用于抑制蛋白激酶如ALK并治疗癌症等疾病的方法。
  • Novel metal complexes containing a chiral trinitrogen isoindoline-based pincer ligand: in situ synthesis and structural characterization
    作者:Jessica L. Cryder、Andrew J. Killgore、Curtis Moore、James A. Golen、Arnold L. Rheingold、Christopher J. A. Daley
    DOI:10.1039/c0dt00869a
    日期:——
    The first synthesis and characterization of metal coordinated complexes containing in situ prepared chiral trinitrogen 1,3-bis(4,5-dihydrooxazol-2-ylimino)isoindoline-based pincer ligands are reported. Two zinc complexes, isolated as Zn(L)2, where L = 1,3-bis(4,5-dihydro-4-(R)-phenyloxazol-2-ylimino)isoindoline ((R,R)-5) or 1,3-bis(4,5-dihydro-4-(S)-iso-propyloxazol-2-ylimino)isoindoline ((S,S)-6), respectively, are reported. Complexes Zn((R,R)-5)2 and Zn((S,S)-6)2 were prepared in situ through the condensation of phthalonitrile with enantiopure 2-amino-4-(R)-phenyloxazoline ((R)-3) or 2-amino-4-(S)-iso-propyloxazoline ((S)-4) in the presence of ZnCl2 at 80 °C in dry toluene over 3–4 days. The characterizations of Zn((R,R)-5)2 and Zn((S,S)-6)2 in both the solid (X-ray crystallography) and solution (multinuclear NMR spectroscopy) states are reported.
    报道了在位合成的含有手性三氮1,3-bis(4,5-dihydrooxazol-2-ylimino)异茚基夹 ligand 的金属配位复合物的首次合成和表征。报道了两个锌复合物,分别为Zn(L)2,其中L = 1,3-bis(4,5-dihydro-4-(R)- phenyloxazol-2-ylimino)异茚 ((R,R)-5) 或 1,3-bis(4,5-dihydro-4-(S)-异丙基氧唑-2-亚胺)异茚 ((S,S)-6)。复合物Zn((R,R)-5)2和Zn((S,S)-6)2是通过在干燥的甲苯中,在80 °C,存在ZnCl2的条件下,通过邻苯二腈与对映体纯的2-amino-4-(R)- phenyloxazoline ((R)-3)或2-amino-4-(S)-异丙基氧唑 ((S)-4)的缩合反应在3-4天内原位制备的。对固态(X射线晶体学)和溶液态(多核NMR光谱)下Zn((R,R)-5)2和Zn((S,S)-6)2的表征结果也进行了报道。
  • BICYCLIC INHIBITORS OF ALK
    申请人:Vasudevan Anil
    公开号:US20140155389A1
    公开(公告)日:2014-06-05
    The present invention relates to compounds of formula (1) or pharmaceutical acceptable salts, wherein R 1 , X, Y, Z, A, B, G 1 , and n are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as ALK and methods of treating diseases such as cancer.
    本发明涉及公式(1)的化合物或药物可接受的盐,其中R1、X、Y、Z、A、B、G1和n在说明书中有定义。本发明还涉及含有所述化合物的组合物,其对抑制激酶如ALK具有用处,以及用于治疗癌症等疾病的方法。
  • Development of Bifunctional Aza-Bis(oxazoline) Copper Catalysts for Enantioselective Henry Reaction
    作者:Kai Lang、Jongwoo Park、Sukwon Hong
    DOI:10.1021/jo1009867
    日期:2010.10.1
    Base-functionalized aza-bis(oxazoline) ligands were prepared to explore the concept of dual activation through the Lewis acid and a tethered tertiary amine base, The catalytic activity of the Cu complex was evaluated for the asymmetric Henry reaction. Compared with a corresponding unfunctionalized copper complex with external 1-benzyl-4-ethylpiperazine base, the ethylpiperazine-functionalized aza-bis(oxazoline) copper catalyst resulted in rate acceleration (2.5 times) as well as improved enantioselectivity (72% ee vs 92% ee).
查看更多

同类化合物

(4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] 香豆素-6-羧酸 锌离子载体IV 钐(III) 离子载体 II 苯,(2,2-二氟乙烯基)- 聚二硫二噻唑烷 缩胆囊肽9 甲酰乙内脲 甲巯咪唑 甲基羟甲基油基噁唑啉 甲基5-羟基-3,5-二甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-氰基-4,5-二氢-1,2-恶唑-3-羧酸酯 甲基5-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-5-氧代-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4,5-二氮杂螺[2.4]庚-5-烯-6-羧酸酯 甲基4,5-二氢-5-乙基-1H-吡唑-1-羧酸酯 甲基(E)-3-[6-[1-羟基-1-(4-甲基苯基)-3-(1-吡咯烷基)丙基]-2-吡啶基]丙烯酰酸酯 甲基(5-氧代-4,5-二氢-1,2-恶唑-3-基)乙酸酯 环戊二烯并[d]咪唑-2,5(1H,3H)-二硫酮 溶剂黄93 溴化1-十六烷基-3-甲基咪唑 溴化1-十二烷基-2,3-二甲基咪唑 泰比培南酯中间体 泰比培南酯中间体 氨基甲硫酸,[2-[[(2-羰基-1-咪唑烷基)硫代甲基]氨基]乙基]-,O-甲基酯 异噻唑,4,5-二氯-2,5-二氢-2-辛基- 希诺米啉 四氟硼酸二氢1,3-二(叔-丁基)-4,5--1H-咪唑正离子 四唑硝基紫 噻唑丁炎酮 噻唑,4,5-二氢-4-(1-甲基乙基)-,(S)- 噁唑,4,5-二氢-4,4-二甲基-2-(5-甲基-2-呋喃基)- 噁唑,2-庚基-4,5-二氢- 咪唑烷基脲 吡嗪,2,3-二氢-5,6-二甲基-2-丙基- 叔-丁基3-羟基-1,4,6,7-四氢吡唑并[4,3-c]吡啶-5-羧酸酯 双吡唑啉酮 双[(S)-4-异丙基-4,5-二氢噁唑-2-基]甲烷 双((R)-4-(叔丁基)-4,5-二氢恶唑-2-基)甲烷 利美尼啶D4 利美尼啶 假硫代乙内酰脲 依达拉奉杂质DO 依达拉奉杂质 依达拉奉三聚体 依达拉奉 仲班酸